| 1 | 08:00-08:30 | 专题报告 |
从医药创新政策看儿科临床药理学发展机遇与挑战 |
|
||||
| 1 | 09:00-09:30 | 专题报告 |
噬菌体治疗多重耐药细菌感染研究进展 |
|
||||
| 2 | 09:30-09:35 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 09:35-09:43 | 大会发言 |
Hepatobiliary disorders associated with triazole antifungal agents: a disproportionality and bayesian analysis based on the FAERS database |
|
||||
| 2 | 09:43-09:51 | 大会发言 |
Development and Validation of Interpretable Machine Learning Models to Predict the Risk of Sub-/Supra-therapeutic Sirolimus Concentration in Children with Vascular Anomalies |
|
||||
| 3 | 09:51-09:59 | 大会发言 |
Predictive Model of Pegasparaginase-Associated Pancreatitis in Pediatric Patients Based on Logistic Regression and Random Forest Algorithms |
|
||||
| 4 | 09:59-10:04 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 11:04-11:34 | 专题报告 |
基于人工智能药物性肝损的研究 |
|
||||
| 2 | 11:34-11:39 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 11:39-11:45 | 大会发言 |
基于机器学习对住院患儿药物性肝损伤风险预测模型的初步开发 |
|
||||
| 2 | 11:45-11:51 | 大会发言 |
Evolution of Drug Development Trends in Multiple Sclerosis: Analysis of China and Global Landscapes from 2004 to 2024 |
|
||||
| 3 | 11:51-11:57 | 大会发言 |
基于FAERS数据库的儿童哌甲酯不良事件信号挖掘及性别差异分析 |
|
||||
| 4 | 11:57-12:03 | 大会发言 |
Prediction Model Study for Cytarabine Syndrome-Related Fever Versus Infectious Fever in Children with Acute Lymphoblastic Leukemia |
|
||||
| 5 | 12:03-12:08 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 12:20-12:40 | 专题会 |
《大环内酯类抗菌药物儿科临床应用专家共识2025》解读 |
|
||||
| 2 | 12:40-13:00 | 专题会 |
儿童呼吸道感染与黏膜上皮屏障 |
|
||||
| 1 | 13:00-13:30 | 专题报告 |
微针递药在类风湿性关节炎治疗中的转化研究 |
|
||||
| 1 | 13:30-14:00 | 专题报告 |
Rett综合征的基因治疗 |
|
||||
| 2 | 14:00-14:05 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 14:05-14:11 | 大会发言 |
整合转录组学与网络药理学揭示灵芝多糖治疗儿童非酒精性脂肪肝的潜在作用机制 |
|
||||
| 2 | 14:11-14:17 | 大会发言 |
基于多组学筛选发现干预硫酸软骨蛋白多糖对亚历山大病中髓鞘的改善作用研究 |
|
||||
| 3 | 14:17-14:23 | 大会发言 |
间充质干细胞对系统性红斑狼疮B1、Tfh细胞的调控作用 |
|
||||
| 4 | 14:23-14:29 | 大会发言 |
下调TLR4/NF-κB炎症通路抑制小胶质细胞介导的过度突触修剪作用改善癫痫后脑损伤的机制研究 |
|
||||
| 1 | 14:29-14:35 | 大会发言 |
花旗松素抑制FABP4减轻炎症和脂质堆积缓解顺铂引起的急性肾损伤 |
|
||||
| 2 | 14:35-14:43 | 大会发言 |
CCCG–BNHL-2015方案治疗儿童BNHL患者的生殖毒性研究 |
|
||||
| 3 | 14:43-14:51 | 大会发言 |
Clinical Insights from a Novel mtDNA Deletion in Pearson Syndrome and Systematic Review of 134 Cases: Building a Prognostic Model |
|
||||
| 4 | 14:51-14:59 | 大会发言 |
Efficacy and safety of clobazam as adjunctive therapy in children of refractory epilepsy: A Real-World Study |
|
||||
| 5 | 14:59-15:04 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 15:04-15:34 | 专题报告 |
AI技术改变疾病治疗策略:从靶点到药物的智能化路径 |
|
||||
| 1 | 15:34-16:04 | 专题报告 |
新质生产力在生物医药创新的临床实践 |
|
||||
| 2 | 16:04-16:09 | 讨论 |
集体答疑、讨论 |
|||||
| 1 | 16:09-16:17 | 大会发言 |
儿童多巴反应性肌张力障碍新的基因型谱及大剂量左旋多巴治疗疗效观察 |
|
||||
| 2 | 16:17-16:25 | 大会发言 |
儿童重症肌无力临床特点及不同免疫治疗方案的疗效分析 |
|
||||
| 3 | 16:25-16:33 | 大会发言 |
Clinical Characteristics and Treatment Outcomes of Upper Airway Cough Syndrome in Children: A Retrospective Study of Bacterial Sinusitis With or Without Allergic Rhinitis |
|
||||
| 4 | 16:33-16:41 | 大会发言 |
生酮饮食对比促肾上腺皮质激素治疗婴儿痉挛症疗效的临床对照研究 |
|
||||
| 5 | 16:41-16:49 | 大会发言 |
Impact of exercise prescription on asthma control and management in Chinese children with asthma |
|
||||
| 1 | 16:49-16:57 | 大会发言 |
驻科药师主导抗菌药物三层智能闭环管理模式的构建与实践 |
|
||||
| 2 | 16:57-17:05 | 大会发言 |
评价皮下注射人免疫球蛋白在原发性免疫缺陷病患者中的有效性、安全性及药代动力学的单臂、多中心临床试验 |
|
||||
| 3 | 17:05-17:13 | 大会发言 |
巴利昔单抗诱导免疫抑制在儿童肝移植术后安全性和有效性的Meta分析 |
|
||||
| 4 | 17:13-17:21 | 大会发言 |
临时调配口服溶剂介质的制备及稳定性研究 |
|
||||
| 5 | 17:21-17:29 | 大会发言 |
Development and Clinical Application of Component-Resolved Diagnostic Using Light-Initiated Chemiluminescence Assay to characterize House Dust Mite Components-Specific IgE |
|
||||
| 1 | 17:29-17:37 | 大会发言 |
儿童过敏性疾病数智化管理工具“敏童管理”小程序的开发与实践研究 |
|
||||
| 2 | 17:37-17:45 | 大会发言 |
MicroRNA-429 inhibits microglial inflammation by targeting IKKβ through the NF-κB pathway |
|
||||
| 3 | 17:45-17:53 | 大会发言 |
NLRP3介导星形胶质细胞焦亡致新生鼠脑白质损伤的机制研究及LIF保护作用 |
|
||||
| 4 | 17:53-18:00 | 讨论 |
集体答疑、讨论 |
|||||